Adagene
Suzhou
About Adagene
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies against novel epitopes. It has its proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $250.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2026)
- Ticker: nasdaq:ADAG
- Website: adagene.com
- Phone: +051287773632
Industries & Categories
Biotechnology, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adagene-89518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.